CRVL CorVel Corp. - Common Stock
NASDAQ · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 6, 2026
$75,47
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$45,0352tyg. minimum
$79,4352tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$3.82B
P/E (TTM)
33.5
EPS (TTM)
$2.25
Przychody (TTM)
$984M
Twoje odznaki
Zakres 52 tyg.
$45–$79
Ocena Analityków
·
Cena Docelowa
·
P/E
33.5
ROE
30.7%
Marża Zysku Netto
11.7%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
CRVL Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$75.47
Kapitalizacja Rynkowa (MRQ)
$3.82B
P/E (TTM)
33.5
EPS (TTM)
$2.25
Przychody (TTM)
$984M
ROE (TTM)
30.7%
Zakres 52 tyg.
$45–$79
CRVL Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Podziały akcji
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 26 grudnia 2024 | 3-for-1 | Naprzód |
| 27 czerwca 2013 | 2-for-1 | Naprzód |
| 11 grudnia 2006 | 3-for-2 | Naprzód |
| 4 września 2001 | 3-for-2 | Naprzód |
| 15 czerwca 1999 | 2-for-1 | Naprzód |
O CorVel Corp. - Common Stock Przegląd firmy z Wikipedii
CorVel Corporation is an American technology company.
History
In 1987, Gordon Clemons joined with Jim Michael and Jeffrey Michael, investors from Minnesota, and founded CorVel Corporation (originally named FORTIS). Three small vocational rehabilitation firms were consolidated to form the initial foundation of the new company, valued at approximately $2 million with over 200 associates.
Within two years, the company expanded to 51 American locations, and they entered the medical bill review and medical case management business.
In 1991, the company first issued stock to the public and began trading on the NASDAQ at a market capitalization value of $46 million. The offering raised $3.5 million, net of the repayment of venture funding. The following year, the Fortis name was sold, raising $4 million and the company changed its name to CorVel Corporation. With the funding from the name sale, CorVel began building a national preferred provider organization (PPO).
During the mid '90s, CorVel doubled its office network again, and expanded its software offerings. PPO services became an important part of most healthcare management sales. Out of network medical review was added to the portfolio of provider programs.
By 2005, CorVel grew to over 2,000 clients and 15% compounded annual stock growth.
In March 2009, the company continued to expand its workers' compensation claims management solutions. During the March quarter, CorVel completed the acquisition of a third party administrator (TPA) in New York, the company's third acquisition in its TPA expansion effort. Software development efforts have been focused on the incorporation of artificial intelligence capabilities and workflow management tools in to the claims' management systems in order to enable CorVel's unique process.
In August 2010, CorVel introduced a provider look up app that can be accessed in the Apple Store and Google Play. This mobile app provides access to locate network doctors, specialists, hospitals and other facilities near the user.
In August 2011, the company also introduced a claim intake app available from Apple that provides mobile access to report workplace incidents and injuries.
In March 2012, the company announced revenues for the quarter ended March 31, 2012, that were a 4% increase over the previous quarter in 2011.
In September 2014, CorVel released a new app (My Care) that provides online access to view indemnity payments, access pharmacy cards, review treatment guidelines and review details of the workplace injury claim. The newest feature of the app provides Touch ID for iPhones that provides secure fingerprint access on iOS devices.
In August 2015, the company announced Telehealth Services as part of their existing Enterprise Comp claims management model to offer immediate access to medical providers for injured workers.
Operations
CorVel had revenues of $592 million for fiscal year ending March 31, 2020.
CorVel is licensed to do business in all 50 states, the District of Columbia and Puerto Rico.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
sektorHealth Care
branżaHealth Care
pracownicy5 239
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$959M2017-03-31 → 2026-03-31
EPS$2.142017-03-31 → 2026-03-31
Wolny przepływ pieniężny$110M2017-03-31 → 2026-03-31
Marża netto11.7%2019-03-31 → 2026-03-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | CRVL | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 33.5średnia z 5 lat ≈42.4 | ≈42.4 | 27.5 | Wartość godziwa | |
| P/S (TTM) | 3.9średnia z 5 lat ≈2.9 | ≈2.9 | 2.1 | Zawyżona wycena | |
| P/B (MRQ) | 9.3średnia z 5 lat ≈8.2 | ≈8.2 | 4.2 | Zawyżona wycena | |
| Cena / FCF (TTM) | 33.5średnia z 5 lat ≈31.1 | ≈31.1 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 25.4średnia z 5 lat ≈21.2 | ≈21.2 | 17.9 | Wartość godziwa | |
| Cena / Wartość księgowa materialna (MRQ) | 9.3średnia z 5 lat ≈9.5 | ≈9.5 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | CRVL | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 24.8%średnia z 5 lat ≈23.0% | ≈23.0% | 29.3% | Zgodnie z | |
| EBITDA Margin (Marża EBITDA) | 3.3%średnia z 5 lat ≈3.4% | ≈3.4% | 5.7% | Słaby | |
| Marża przed opodatkowaniem (TTM) | 15.4%średnia z 5 lat ≈13.0% | ≈13.0% | 5.7% | Najwyższa półka | |
| Marża Zysku Netto (TTM) | 11.7%średnia z 5 lat ≈10.2% | ≈10.2% | 4.6% | Najwyższa półka | |
| ROA (TTM) | 17.9%średnia z 5 lat ≈17.6% | ≈17.6% | 1.7% | Najwyższa półka | |
| ROE (TTM) | 30.7%średnia z 5 lat ≈31.2% | ≈31.2% | 4.9% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | CRVL | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 1.9średnia z 5 lat ≈1.7 | ≈1.7 | 1.6 | Silna płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 1.5średnia z 5 lat ≈1.2 | ≈1.2 | 1.3 | Zgodnie z |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | CRVL | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 7.0%średnia z 5 lat ≈11.7% | ≈11.7% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 10.1%średnia z 5 lat ≈11.5% | ≈11.5% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 11.6% | · | · | · | |
| EPS YoY | 16.9%średnia z 5 lat ≈7.2% | ≈7.2% | · | · | |
| Net Income YoY (Zysk Netto R/R) | 16.0%średnia z 5 lat ≈19.8% | ≈19.8% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 19.3%średnia z 5 lat ≈-6.0% | ≈-6.0% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | -3.5% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 18.5%średnia z 5 lat ≈16.4% | ≈16.4% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | 18.9% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | CRVL | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 1.6średnia z 5 lat ≈1.7 | ≈1.7 | 1.5 | Zgodnie z | |
| Receivables Turnover (Rotacja należności) | 9.3średnia z 5 lat ≈8.9 | ≈8.9 | 9.9 | Zgodnie z | |
| Revenue / Employee (Przychody / pracownika) | ≈$183.0K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Następny raport
Lis 02, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 31 grudnia 2026 | Maj 20, 2026 | $0.61 | — | — |
| 30 września 2026 | Lis 2, 2026 | $0.47 | — | — |
| 30 września 2025 | $0.46 | — | — | |
| 31 marca 2025 | $1.25 | — | — | |
| 30 września 2024 | $0.99 | — | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $959M | $896M | $795M | $719M | $646M | $553M | $592M | $596M | $558M | $519M | |
| Cost of Revenue | $726M | $686M | $624M | $560M | $494M | $429M | $466M | $471M | $451M | $414M | |
| Gross Profit | $233M | $210M | $172M | $158M | $152M | $124M | $126M | $125M | $107M | $105M | |
| SG&A Expense | $90M | $89M | $77M | $74M | $68M | $64M | $65M | $63M | $59M | $57M | |
| Pretax Income | $143M | $121M | $95M | $85M | $85M | $59M | $61M | $62M | $48M | $48M | |
| Income Tax | $33M | $26M | $19M | $18M | $18M | $13M | $13M | $15M | $12M | $18M | |
| Net Income | $110M | $95M | $76M | $66M | $66M | $46M | $47M | $47M | $36M | $29M | |
| EPS (Basic) | $2.15 | $1.85 | $1.48 | $1.28 | $3.74 | $2.59 | $2.59 | $2.48 | $1.90 | $1.52 | |
| EPS (Diluted) | $2.14 | $1.83 | $1.47 | $1.26 | $3.66 | $2.55 | $2.55 | $2.46 | $1.87 | $1.51 | |
| Shares (Basic) | 51,283,000 | 51,379,000 | 51,366,000 | 51,984,000 | 17,753,000 | 17,930,000 | 18,326,000 | 18,794,000 | 18,825,000 | 19,418,000 | |
| Shares (Diluted) | 51,625,000 | 51,994,000 | 52,041,000 | 52,776,000 | 18,127,000 | 18,166,000 | 18,602,000 | 19,008,000 | 19,042,000 | 19,570,000 | |
| EBITDA | $32M | $30M | $26M | $25M | $24M | $23M | · | $23M | $22M | $21M |
Bilans
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $233M | $171M | $106M | $71M | $98M | $140M | $83M | $92M | $56M | $29M | |
| Receivables | $101M | $104M | $97M | $81M | $83M | $65M | $66M | $71M | $65M | $63M | |
| Prepaid Expense | $12M | $11M | $11M | $11M | $15M | $8M | $11M | $7M | $7M | $5M | |
| Current Assets | $462M | $387M | $302M | $244M | $265M | $269M | $209M | $215M | $163M | $129M | |
| PP&E (Net) | $118M | $92M | $86M | $83M | $76M | $71M | $76M | $62M | $69M | $63M | |
| PP&E (Gross) | $381M | $334M | $309M | $300M | $284M | $259M | $243M | $240M | $231M | $207M | |
| Accum. Depreciation | $263M | $241M | $223M | $217M | $208M | $189M | $167M | $178M | $161M | $144M | |
| Goodwill | $37M | $37M | $37M | $37M | $37M | $37M | $37M | $37M | $37M | $37M | |
| Intangibles | $263.0K | $438.0K | $821.0K | $1M | $2M | $2M | $3M | $3M | $3M | $4M | |
| Other Non-current Assets | $618.0K | $454.0K | $1M | $1M | $481.0K | $345.0K | $1M | $756.0K | $1M | $3M | |
| Total Assets | $643M | $546M | $455M | $394M | $415M | $425M | $416M | $318M | $274M | $235M | |
| Accounts Payable | $24M | $15M | $16M | $15M | $14M | $12M | $15M | $10M | $12M | $14M | |
| Accrued Liabilities | $204M | $187M | $168M | $153M | $157M | $149M | $117M | $105M | $85M | $73M | |
| Current Liabilities | $228M | $204M | $184M | $168M | $171M | $162M | $134M | $117M | $98M | $90M | |
| Capital Leases | $21M | $20M | $23M | $24M | $30M | $42M | $85M | $0 | · | · | |
| Deferred Tax | · | · | · | $0 | $2M | $0 | $8M | $6M | $5M | $7M | |
| Total Liabilities | $249M | $224M | $207M | $192M | $203M | $204M | $227M | $123M | $103M | $97M | |
| Common Stock | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Retained Earnings | $1.01B | $903M | $808M | $732M | $665M | $599M | $553M | $505M | $458M | $423M | |
| Treasury Stock | $888M | $832M | $794M | $748M | $655M | $564M | $532M | $466M | $431M | $420M | |
| Stockholders' Equity | $394M | $322M | $248M | $202M | $212M | $220M | $190M | $195M | $171M | $139M | |
| Liabilities + Equity | $643M | $546M | $455M | $394M | $415M | $425M | $416M | $318M | $274M | $235M | |
| Shares Outstanding | 50,909,297 | 51,359,544 | 51,386,688 | 17,169,500 | 17,569,087 | 17,876,090 | 17,968,966 | 18,557,794 | 18,912,907 | 18,937,233 |
Przepływy pieniężne
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $32M | $30M | $26M | $25M | $24M | $23M | $23M | $23M | $22M | $21M | |
| Stock-based Comp | $5M | $6M | $5M | $6M | $5M | $5M | $4M | $4M | $3M | $2M | |
| Deferred Tax | $5M | $-5M | $-3M | $-2M | $2M | $-8M | $1M | $1M | $-874.0K | $-1M | |
| Amort. of Intangibles | $175.0K | $383.0K | $423.0K | $425.0K | $435.0K | $435.0K | $435.0K | $440.0K | $437.0K | $437.0K | |
| Other Non-cash | $3M | $2M | $-5M | $-13M | $-31M | $28M | · | $3M | $2M | $413.0K | |
| Operating Cash Flow | $156M | $127M | $99M | $82M | $67M | $94M | $81M | $79M | $62M | $52M | |
| CapEx | $45M | $36M | $29M | $26M | $30M | $17M | $32M | $15M | $28M | $31M | |
| Investing Cash Flow | $-45M | $-36M | $-29M | $-26M | $-30M | $-17M | $-32M | $-15M | $-28M | $-31M | |
| Stock Repurchased | $56M | $38M | $46M | $94M | $90M | $33M | $66M | $35M | $11M | $28M | |
| Net Stock Activity | $-56M | $-38M | $-46M | $-94M | $-90M | $-33M | · | $-35M | $-11M | $-28M | |
| Financing Cash Flow | $-48M | $-27M | $-36M | $-82M | $-80M | $-21M | $-57M | $-27M | $-7M | $-25M | |
| Net Change in Cash | $62M | $65M | $34M | $-26M | $-42M | $56M | $-8M | $36M | $27M | $-4M | |
| Taxes Paid | $31M | $28M | $23M | · | · | · | · | · | · | · | |
| Free Cash Flow | $110M | $92M | $70M | $56M | $37M | $77M | · | $63M | $34M | $21M |
Rentowność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 24.3% | 23.4% | 21.6% | 22.0% | 23.5% | 22.4% | · | 20.9% | · | · | |
| Net Margin | 11.5% | 10.6% | 9.6% | 9.2% | 10.3% | 8.4% | · | 7.8% | · | · | |
| Pretax Margin | 14.9% | 13.5% | 12.0% | 11.8% | 13.1% | 10.7% | · | 10.3% | · | · | |
| EBITDA Margin | 3.3% | 3.3% | 3.3% | 3.5% | 3.7% | 4.2% | · | 3.9% | · | · | |
| ROA | 18.6% | 19.0% | 18.0% | 16.4% | 15.8% | 11.0% | · | 15.8% | 14.0% | 12.9% | |
| ROE | 29.1% | 30.6% | 31.7% | 33.4% | 31.1% | 21.6% | · | 24.1% | 21.5% | 21.8% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.9 | 1.6 | 1.5 | 1.5 | 1.7 | · | 1.8 | 1.7 | 1.4 | |
| Quick Ratio | 1.5 | 1.3 | 1.1 | 0.9 | 1.1 | 1.3 | · | 1.4 | 1.2 | 1.0 |
Efektywność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.6 | 1.8 | 1.9 | 1.8 | 1.5 | 1.3 | · | 2.0 | · | · | |
| Receivables Turnover | 9.3 | 8.9 | 8.9 | 8.8 | 8.8 | 8.5 | · | 8.7 | · | · |
Na akcję
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.74 | $6.27 | $14.46 | $11.78 | $12.09 | $12.33 | · | $10.50 | $9.05 | $7.32 | |
| Revenue / Share | $18.57 | $17.22 | $45.85 | $40.85 | $35.65 | $30.42 | · | $31.34 | · | · | |
| Cash Flow / Share | $3.01 | $2.45 | $5.72 | $4.68 | $3.71 | $5.20 | · | $4.14 | $3.26 | $2.66 | |
| Cash / Share | $4.58 | $3.32 | $6.16 | $4.15 | $5.55 | $7.82 | · | $4.94 | $2.95 | $1.51 | |
| EPS (TTM) | $2.14 | $1.83 | $1.47 | $1.26 | $3.66 | $2.55 | $2.55 | $2.46 | $1.87 | $1.51 |
Stopy Wzrostu
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.0% | 12.6% | 10.7% | 11.2% | 16.9% | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.1% | 11.5% | 12.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.6% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 16.9% | 24.5% | 16.7% | -65.6% | 43.5% | · | · | · | · | · | |
| EPS CAGR 3Y | 19.3% | -20.6% | -16.8% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.5% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 16.0% | 24.8% | 14.9% | -0.07% | 43.3% | · | · | · | · | · | |
| Net Income CAGR 3Y | 18.5% | 12.7% | 18.1% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 18.9% | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $959M | $896M | $795M | $719M | $646M | $553M | $592M | $596M | $558M | $519M | |
| Net Income TTM | $110M | $95M | $76M | $66M | $66M | $46M | $47M | $47M | $36M | $29M | |
| Market Cap | $2.78B | $5.75B | $1.50B | $1.09B | $986M | $611M | · | $404M | $319M | $275M | |
| P/E | 25.5 | 61.2 | 59.6 | 50.3 | 15.3 | 13.4 | 7.1 | 8.8 | 9.0 | 9.6 | |
| P/S | 2.9 | 6.4 | 1.9 | 1.5 | 1.5 | 1.1 | · | 0.7 | 0.6 | 0.5 | |
| P/B | 7.1 | 17.9 | 6.1 | 5.4 | 4.6 | 2.8 | · | 2.1 | 1.9 | 2.0 | |
| P / Tangible Book | 7.8 | 20.2 | 7.1 | 6.6 | 5.7 | 3.4 | · | · | · | · | |
| P / Cash Flow | 17.9 | 45.2 | 15.1 | 13.2 | 14.7 | 6.5 | · | 5.1 | 5.1 | 5.3 | |
| P / FCF | 25.2 | 62.8 | 21.4 | 19.5 | 26.4 | 7.9 | · | 6.4 | 9.2 | 13.1 | |
| Earnings Yield | 3.9% | 1.6% | 1.7% | 2.0% | 6.5% | 7.5% | 14.0% | 11.3% | 11.1% | 10.4% |
Rachunek zysków i strat
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $260M | $249M | $236M | $240M | $235M | $232M | $228M | $224M | $212M | $207M | $202M | $196M | $190M | $185M | $179M | $177M | |
| Cost of Revenue | $192M | $186M | $181M | $181M | $178M | $174M | $175M | $174M | $164M | $164M | $160M | $151M | $148M | $143M | $139M | $141M | |
| Gross Profit | $68M | $63M | $55M | $58M | $57M | $58M | $53M | $51M | $48M | $43M | $42M | $44M | $42M | $42M | $40M | $36M | |
| SG&A Expense | $24M | $23M | $23M | $22M | $21M | $25M | $22M | $22M | $20M | $21M | $20M | $20M | $16M | $19M | $18M | $18M | |
| Pretax Income | $43M | $40M | $32M | $36M | $35M | $33M | $31M | $29M | $28M | $23M | $22M | $25M | $25M | $23M | $22M | $19M | |
| Income Tax | $11M | $9M | $8M | $8M | $8M | $7M | $7M | $5M | $6M | $3M | $5M | $5M | $6M | $4M | $5M | $4M | |
| Net Income | $32M | $31M | $24M | $28M | $27M | $26M | $24M | $23M | $22M | $19M | $17M | $20M | $20M | $18M | $17M | $15M | |
| EPS (Basic) | $0.63 | $0.61 | $0.47 | $0.54 | $0.53 | $0.51 | $0.46 | $0.46 | $0.42 | $-1.17 | $0.33 | $1.16 | $1.16 | $-1.49 | $0.98 | $0.84 | |
| EPS (Diluted) | $0.63 | $0.61 | $0.47 | $0.54 | $0.52 | $0.50 | $0.46 | $0.45 | $0.42 | $-1.15 | $0.33 | $1.15 | $1.14 | $-1.47 | $0.96 | $0.83 | |
| Shares (Basic) | 50,804,000 | · | 51,317,000 | 51,314,000 | 51,352,000 | · | 51,388,000 | 51,399,000 | 51,366,000 | · | 51,318,000 | 17,123,000 | 17,144,000 | · | 17,245,000 | 17,386,000 | |
| Shares (Diluted) | 50,928,000 | · | 51,582,000 | 51,723,000 | 51,912,000 | · | 52,038,000 | 52,023,000 | 51,939,000 | · | 51,978,000 | 17,346,000 | 17,385,000 | · | 17,487,000 | 17,650,000 | |
| EBITDA | $9M | · | · | · | $8M | · | · | · | $7M | · | · | · | $6M | · | · | · |
Bilans
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $256M | $233M | $230M | $207M | $202M | $171M | $163M | $138M | $132M | $106M | $107M | $92M | $87M | · | $78M | $76M | |
| Receivables | $111M | $101M | $102M | $105M | $102M | $104M | $106M | $102M | $98M | $97M | $93M | $87M | $84M | · | $83M | $85M | |
| Prepaid Expense | $11M | $12M | $16M | $10M | $9M | $11M | $15M | $13M | $10M | $11M | $14M | $13M | $12M | · | $13M | $12M | |
| Current Assets | $505M | $462M | $464M | $434M | $422M | $387M | $383M | $363M | $333M | $302M | $294M | $282M | $268M | · | $257M | $248M | |
| PP&E (Net) | $122M | $118M | $114M | $111M | $108M | $92M | $91M | $89M | $87M | $86M | $85M | $85M | $84M | · | $82M | $83M | |
| PP&E (Gross) | · | $381M | · | · | · | $334M | · | · | · | $309M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $263M | · | · | · | $241M | · | · | · | $223M | · | · | · | · | · | · | |
| Goodwill | $37M | $37M | $37M | $37M | $37M | $37M | $37M | $37M | $37M | $37M | $37M | $37M | $37M | · | $37M | $37M | |
| Intangibles | $219.0K | $263.0K | $307.0K | $350.0K | $394.0K | $438.0K | $505.0K | $611.0K | $716.0K | $821.0K | $927.0K | $1M | $1M | · | $1M | $1M | |
| Other Non-current Assets | $1M | $618.0K | $423.0K | $490.0K | $512.0K | $454.0K | $462.0K | $679.0K | $1M | $1M | $1M | $1M | $723.0K | · | $778.0K | $797.0K | |
| Total Assets | $690M | $643M | $645M | $612M | $597M | $546M | $539M | $519M | $486M | $455M | $445M | $434M | $418M | · | $408M | $400M | |
| Accounts Payable | $20M | $24M | $26M | $19M | $21M | $15M | $15M | $14M | $12M | $16M | $15M | $15M | $15M | · | $15M | $17M | |
| Accrued Liabilities | $230M | $204M | $220M | $207M | $205M | $187M | $200M | $199M | $182M | $168M | $173M | $171M | $167M | · | $170M | $158M | |
| Current Liabilities | $260M | $228M | $250M | $230M | $235M | $204M | $217M | $213M | $201M | $184M | $188M | $186M | $188M | · | $186M | $176M | |
| Capital Leases | $21M | $21M | $19M | $19M | $20M | $20M | $21M | $23M | $22M | $23M | $23M | $25M | $23M | · | $26M | $25M | |
| Total Liabilities | $281M | $249M | $269M | $249M | $255M | $224M | $238M | $236M | $222M | $207M | $211M | $212M | $211M | · | $213M | $202M | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | $3.0K | $3.0K | |
| Retained Earnings | $1.05B | $1.01B | $982M | $958M | $930M | $903M | $877M | $853M | $829M | $808M | $788M | $771M | $751M | · | $713M | $697M | |
| Treasury Stock | $910M | $888M | $868M | $854M | $841M | $832M | $823M | $813M | $803M | · | $785M | $775M | $766M | · | $730M | $707M | |
| Stockholders' Equity | $409M | $394M | $376M | $363M | $343M | $322M | $301M | $283M | $264M | $248M | $234M | $223M | $207M | $202M | $195M | $198M | |
| Liabilities + Equity | $690M | $643M | $645M | $612M | $597M | $546M | $539M | $519M | $486M | $455M | $445M | $434M | $418M | · | $408M | $400M | |
| Shares Outstanding | 50,596,284 | 50,909,297 | 51,143,561 | 51,293,374 | 51,325,363 | 51,359,544 | 51,367,173 | 17,135,160 | 17,123,561 | 51,386,688 | 17,099,318 | 17,119,483 | 17,113,915 | · | 17,180,180 | 17,314,186 |
Przepływy pieniężne
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $8M | $8M | $8M | $8M | $8M | $7M | $8M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | |
| Stock-based Comp | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $950.0K | |
| Deferred Tax | $-340.0K | $6M | $-341.0K | $-349.0K | $-355.0K | $-4M | $-456.0K | $-370.0K | $-268.0K | $-2M | $-270.0K | $-325.0K | $-328.0K | $-907.0K | $-424.0K | $-238.0K | |
| Other Non-cash | $8M | · | · | · | $19M | · | · | · | $11M | · | · | · | $9M | · | · | · | |
| Operating Cash Flow | $50M | $29M | $46M | $25M | $55M | $23M | $42M | $22M | $40M | $15M | $29M | $18M | $37M | $13M | $30M | $10M | |
| CapEx | $7M | $9M | $11M | $10M | $15M | $9M | $10M | $10M | $8M | $10M | $7M | $7M | $5M | $7M | $6M | $5M | |
| Investing Cash Flow | $-7M | $-9M | $-11M | $-10M | $-15M | $-9M | $-10M | $-10M | $-8M | $-10M | $-7M | $-7M | $-5M | $-7M | $-6M | $-5M | |
| Stock Repurchased | $22M | $20M | $14M | $13M | $10M | $9M | $9M | $10M | $10M | $9M | $9M | $9M | $18M | $19M | $23M | $26M | |
| Net Stock Activity | $-22M | · | · | · | $-10M | · | · | · | $-10M | · | · | · | $-18M | · | · | · | |
| Financing Cash Flow | $-20M | $-17M | $-13M | $-10M | $-8M | $-7M | $-8M | $-6M | $-6M | $-7M | $-7M | $-6M | $-16M | $-12M | $-22M | $-23M | |
| Net Change in Cash | $23M | $3M | $23M | $5M | $31M | $8M | $25M | $6M | $26M | $-1M | $15M | $5M | $15M | $-7M | $2M | $-19M | |
| Free Cash Flow | $43M | · | · | · | $40M | · | · | · | $33M | · | · | · | $32M | · | · | · |
Rentowność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 26.1% | · | 23.3% | 24.3% | 24.2% | · | 23.2% | 22.6% | 22.7% | · | 20.8% | 22.6% | 22.0% | · | 22.5% | 20.3% | |
| Net Margin | 12.4% | · | 10.3% | 11.6% | 11.6% | · | 10.4% | 10.4% | 10.2% | · | 8.5% | 10.2% | 10.4% | · | 9.4% | 8.3% | |
| Pretax Margin | 16.7% | · | 13.7% | 15.0% | 15.0% | · | 13.5% | 12.8% | 13.2% | · | 11.1% | 12.6% | 13.4% | · | 12.4% | 10.4% | |
| EBITDA Margin | 3.4% | · | · | · | 3.2% | · | · | · | 3.2% | · | · | · | 3.4% | · | · | · | |
| ROA | 5.0% | · | 4.1% | 4.9% | 5.0% | · | 4.8% | 4.9% | 4.8% | · | 4.0% | 4.8% | 4.8% | · | 4.0% | 3.5% | |
| ROE | 8.6% | · | 7.1% | 8.6% | 9.0% | · | 8.9% | 9.3% | 9.2% | · | 8.0% | 9.5% | 9.6% | · | 8.2% | 7.0% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | · | 1.9 | 1.9 | 1.8 | · | 1.8 | 1.7 | 1.7 | · | 1.6 | 1.5 | 1.4 | · | 1.4 | 1.4 | |
| Quick Ratio | 1.4 | · | 1.3 | 1.4 | 1.3 | · | 1.2 | 1.1 | 1.1 | · | 1.1 | 1.0 | 0.9 | · | 0.9 | 0.9 |
Efektywność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.4 | |
| Receivables Turnover | 2.4 | · | 2.3 | 2.3 | 2.4 | · | 2.3 | 2.4 | 2.3 | · | 2.3 | 2.3 | 2.3 | · | 2.4 | 2.3 |
Na akcję
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.08 | · | $7.35 | $7.07 | $6.67 | · | $5.86 | $16.50 | $15.41 | · | $13.66 | $13.00 | $12.09 | · | $11.34 | $11.43 | |
| Revenue / Share | $5.10 | · | $4.57 | $4.63 | $4.52 | · | $4.38 | $12.94 | $12.23 | · | $11.68 | $11.27 | $10.94 | · | $10.26 | $10.05 | |
| Cash Flow / Share | $0.98 | · | · | · | $1.06 | · | · | · | $2.34 | · | · | · | $2.11 | · | · | · | |
| Cash / Share | $5.06 | · | $4.50 | $4.04 | $3.94 | · | $3.17 | $8.07 | $7.70 | · | $6.26 | $5.36 | $5.06 | · | $4.54 | $4.37 | |
| EPS (TTM) | $2.25 | · | $2.03 | $2.02 | $1.93 | · | $0.18 | $0.05 | $0.75 | · | $1.15 | $1.78 | $1.46 | · | $3.83 | $3.63 |
Wycena (TTM)
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $984M | · | $941M | $934M | $919M | · | $871M | $846M | $817M | · | $774M | $751M | $733M | · | $704M | $690M | |
| Net Income TTM | $115M | · | $106M | $105M | $101M | · | $88M | $82M | $78M | · | $75M | $75M | $69M | · | $68M | $65M | |
| Market Cap | $3.16B | · | $3.46B | $3.97B | $5.28B | · | $5.72B | $1.87B | $1.45B | · | $1.41B | $1.12B | $1.10B | · | $832M | $799M | |
| P/E | 27.8 | · | 33.3 | 38.3 | 53.3 | · | 618.1 | 2179.3 | 113.0 | · | 71.7 | 36.8 | 44.2 | · | 12.6 | 12.7 | |
| P/S | 3.2 | · | 3.7 | 4.3 | 5.7 | · | 6.6 | 2.2 | 1.8 | · | 1.8 | 1.5 | 1.5 | · | 1.2 | 1.2 | |
| P/B | 7.7 | · | 9.2 | 10.9 | 15.4 | · | 19.0 | 6.6 | 5.5 | · | 6.0 | 5.0 | 5.3 | · | 4.3 | 4.0 | |
| P / Tangible Book | 8.5 | · | 10.2 | 12.2 | 17.3 | · | 21.7 | 7.6 | 6.4 | · | 7.2 | 6.1 | 6.5 | · | 5.3 | 5.0 | |
| P / Cash Flow | 63.4 | · | · | · | 95.9 | · | · | · | 35.9 | · | · | · | 30.1 | · | · | · | |
| Earnings Yield | 3.6% | · | 3.0% | 2.6% | 1.9% | · | 0.16% | 0.05% | 0.88% | · | 1.4% | 2.7% | 2.3% | · | 7.9% | 7.9% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Przychody | $959M | $896M | $795M | $719M | $646M |
| Marża Brutto % | 24.3% | 23.4% | 21.6% | 22.0% | 23.5% |
| Zysk netto | $110M | $95M | $76M | $66M | $66M |
| Rozwodniony EPS | $2.14 | $1.83 | $1.47 | $1.26 | $3.66 |
| Wskaźnik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 2.0 | 1.9 | 1.6 | 1.5 | 1.5 |
| Wskaźnik Szybkości | 1.5 | 1.3 | 1.1 | 0.9 | 1.1 |
| Wskaźnik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $110M | $92M | $70M | $56M | $37M |
Właściciele instytucjonalni (13F) 302 emitenci · $1.9B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
302
Wartość posiadanych akcji
$1.9B
Nowe pozycje
39
Zamknięte pozycje
30
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 39 (-14 vs poprzedni kw.) | 30 (-10 vs poprzedni kw.) | 127 (+4 vs poprzedni kw.) | 72 (-4 vs poprzedni kw.) | +731K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $321 315 654 | 5 139 406 | 16,49% | Akcje |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $284 540 719 | 4 551 195 | 14,60% | Akcje |
| VANGUARD GROUP INC | $219 326 049 | 3 241 112 | 11,25% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $107 526 648 | 1 719 876 | 5,52% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $95 626 216 | 1 529 530 | 4,91% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $81 169 841 | 1 298 302 | 4,16% | Akcje |
| STATE STREET CORP | $80 603 722 | 1 289 247 | 4,14% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $71 026 948 | 1 136 109 | 3,64% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $63 378 741 | 1 013 570 | 3,25% | Akcje |
| MORGAN STANLEY | $40 994 405 | 655 700 | 2,10% | Akcje |
| WELLS FARGO & COMPANY/MN | $28 330 876 | 453 149 | 1,45% | Akcje |
| Boston Trust Walden Corp | $25 946 613 | 415 013 | 1,33% | Akcje |
| NORTHERN TRUST CORP | $25 658 959 | 410 412 | 1,32% | Akcje |
| Owls Nest Partners IA, LLC | $25 487 591 | 407 671 | 1,31% | Akcje |
| ALGERT GLOBAL LLC | $23 971 356 | 383 419 | 1,23% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $22 444 629 | 358 999 | 1,15% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $19 559 069 | 312 845 | 1,00% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $16 975 180 | 271 516 | 0,87% | Akcje |
| GOLDMAN SACHS GROUP INC | $15 738 347 | 251 733 | 0,81% | Akcje |
| MARSHALL WACE, LLP | $13 872 125 | 221 883 | 0,71% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $13 710 073 | 219 291 | 0,70% | Akcje |
| Bank of New York Mellon Corp | $11 438 846 | 182 963 | 0,59% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $11 378 265 | 181 994 | 0,58% | Akcje |
| Rockefeller Capital Management L.P. | $9 384 502 | 150 104 | 0,48% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $9 090 971 | 145 409 | 0,47% | Akcje |
| NORGES BANK | $8 652 768 | 138 400 | 0,44% | Akcje |
| Creative Planning | $8 255 459 | 132 045 | 0,42% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $8 174 052 | 130 743 | 0,42% | Akcje |
| BANK OF AMERICA CORP /DE/ | $8 072 707 | 129 122 | 0,41% | Akcje |
| Invesco Ltd. | $7 299 397 | 116 753 | 0,37% | Akcje |
| Grantham, Mayo, Van Otterloo & Co. LLC | $7 253 695 | 116 022 | 0,37% | Akcje |
| JPMORGAN CHASE & CO | $6 779 651 | 108 597 | 0,35% | Akcje |
| Public Sector Pension Investment Board | $6 693 829 | 107 067 | 0,34% | Akcje |
| Quantinno Capital Management LP | $6 610 365 | 105 732 | 0,34% | Akcje |
| Granahan Investment Management, LLC | $6 600 174 | 105 569 | 0,34% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $6 381 416 | 102 070 | 0,33% | Akcje |
| Assenagon Asset Management S.A. | $6 374 039 | 101 952 | 0,33% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $6 302 329 | 100 805 | 0,32% | Akcje |
| UBS Group AG | $6 239 933 | 99 807 | 0,32% | Akcje |
| Cubist Systematic Strategies, LLC | $5 279 083 | 68 188 | 0,27% | Akcje |
| West Coast Financial LLC | $4 984 009 | 44 512 | 0,26% | Akcje |
| Nuveen, LLC | $4 970 778 | 79 507 | 0,26% | Akcje |
| RHUMBLINE ADVISERS | $4 969 504 | 79 487 | 0,25% | Akcje |
| Qube Research & Technologies Ltd | $4 960 462 | 79 342 | 0,25% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $4 790 619 | 87 660 | 0,25% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $4 619 790 | 73 893 | 0,24% | Akcje |
| Russell Investments Group, Ltd. | $4 598 533 | 73 553 | 0,24% | Akcje |
| Legal & General Group Plc | $4 263 238 | 68 190 | 0,22% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $4 250 349 | 77 774 | 0,22% | Akcje |
| SEI INVESTMENTS CO | $4 162 656 | 66 581 | 0,21% | Akcje |
Insiderzy spółki 24 insiderów · 12 dyrektorzy generalni · 4 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Michael G Combs | CEO & President | 30 września 2026 A | 12 367 | 0 | 6 | $-2 164 447 |
| Sarah A. Scott | CEO and President | 1 lipca 2026 A | · | 0 | 0 | $0 |
| Brian S. Nichols | Chief Financial Officer | 30 września 2026 A | 65 | 0 | 0 | $0 |
| Brandon O'Brien | Chief Financial Officer | 8 września 2025 S | 8 948 | 0 | 0 | $0 |
| Richard J Schweppe | Chief Financial Officer | 27 grudnia 2017 M | 1 206 | 0 | 0 | $0 |
| Mark E. Bertels | EVP - Risk Management Services | 30 września 2026 A | 2 918 | 0 | 1 | $-86 820 |
| Jennifer Yoss | Vice President of Accounting | 30 września 2026 A | 2 209 | 0 | 4 | $-270 911 |
| Maxim Shishin | Chief Information Officer | 12 czerwca 2026 M | 7 050 | 0 | 2 | $-265 928 |
| Gordon V Clemons | Chairman of the Board | 2 grudnia 2024 S | 241 584 | 0 | 0 | $0 |
| Diane Blaha | Chief Marketing Officer | 14 kwietnia 2022 M | 5 423 | 0 | 0 | $0 |
| Michael Saverien | Exec. VP, Risk Mgmt. Services | 5 listopada 2019 A | 6 308 | 0 | 0 | $0 |
| Gordon V. Clemons JR | Executive Vice President | 17 sierpnia 2012 S | 0 | 0 | 0 | $0 |
| Judd R Jessup | Dyrektor | 1 września 2026 S | 111 798 | 0 | 6 | $-1 289 354 |
| Joanna M. Burkey | Dyrektor | 6 sierpnia 2026 A | · | 0 | 0 | $0 |
| Jean Macino | Dyrektor | 25 lipca 2024 M | 16 758 | 0 | 0 | $0 |
| CORSTAR HOLDINGS INC | Posiadacz 10% | 14 września 2026 S | 18 517 108 | 0 | 4 | $-15 666 679 |
| Alan Hoops | · | 6 sierpnia 2026 A | 33 192 | 0 | 0 | $0 |
| Steven J Hamerslag | · | 6 sierpnia 2026 A | 287 000 | 0 | 2 | $-955 800 |
| MICHAEL JEFFREY J | · | 6 sierpnia 2026 A | 559 721 | 0 | 1 | $-548 820 |
| Donald C Mcfarlane | · | 26 lutego 2015 M | 4 060 | 0 | 0 | $0 |
| Scott R Mccloud | · | 8 maja 2014 A | 12 758 | 0 | 0 | $0 |
| Daniel J Starck | · | 16 lutego 2012 S | 25 768 | 0 | 0 | $0 |
| Edwin Hendrick | · | 7 listopada 2006 A | · | 0 | 0 | $0 |
| Peter E Flynn | · | 20 sierpnia 2004 S | 11 000 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 52 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,26% | 29 266 SH | 2 października 2026 | Dziennie |
| SCOW · Pacer Funds Trust | 0,71% | 201 NS | 31 lipca 2026 | N-PORT |
| XSHQ · Invesco Exchange-Traded Fund Trust … | 0,68% | 26 400 SH | 2 października 2026 | Dziennie |
| IHF · iShares Trust | 0,31% | 59 956 SH | 11 września 2026 | Dziennie |
| VFQY · VANGUARD WELLINGTON FUND | 0,18% | 14 006 SH | 19 sierpnia 2026 | Dziennie |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,16% | 4 893 SH | 2 października 2026 | Dziennie |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 15 055 NS | 31 lipca 2026 | N-PORT |
| IWO · iShares Trust | 0,13% | 278 000 SH | 11 września 2026 | Dziennie |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,13% | 23 027 SH | 19 sierpnia 2026 | Dziennie |
| QIDX · Spinnaker ETF Series | 0,13% | 866 NS | 31 lipca 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,13% | 27 545 NS | 31 lipca 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,11% | 109 200 SH | 19 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,11% | 31 693 SH | 19 sierpnia 2026 | Dziennie |
| ROSC · Lattice Strategies Trust | 0,09% | 917 NS | 31 lipca 2026 | N-PORT |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,08% | 25 160 SH | 19 sierpnia 2026 | Dziennie |
| ESML · iShares Trust | 0,08% | 31 537 SH | 11 września 2026 | Dziennie |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,07% | 18 683 SH | 2 października 2026 | Dziennie |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 8 029 NS | 31 lipca 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,07% | 24 529 SH | 2 października 2026 | Dziennie |
| BKSE · BNY Mellon ETF Trust | 0,07% | 1 001 NS | 31 lipca 2026 | N-PORT |
| ISCG · iShares Trust | 0,07% | 9 442 SH | 11 września 2026 | Dziennie |
| IWM · iShares Trust | 0,07% | 754 007 SH | 11 września 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 169 983 SH | 19 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,06% | 148 691 NS | 31 lipca 2026 | N-PORT |
| RSSL · Global X Funds | 0,06% | 14 124 NS | 31 lipca 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,05% | 370 536 SH | 19 sierpnia 2026 | Dziennie |
| TEXN · iShares Trust | 0,04% | 99 SH | 11 września 2026 | Dziennie |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,03% | 1 064 SH | 2 października 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,03% | 84 683 SH | 19 sierpnia 2026 | Dziennie |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,03% | 2 497 NS | 31 lipca 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 13 368 NS | 31 lipca 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 358 654 SH | 19 sierpnia 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,02% | 640 211 SH | 19 sierpnia 2026 | Dziennie |
| WSML · iShares Trust | 0,02% | 1 723 SH | 11 września 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,01% | 65 667 NS | 31 lipca 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 663 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 1 952 NS | 31 lipca 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 1 296 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 6 389 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 41 470 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 7 849 SH | 4 września 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,00% | 4 572 NS | 31 lipca 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 890 953 SH | 19 sierpnia 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 20 351 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 376 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,00% | 6 485 SH | 19 sierpnia 2026 | Dziennie |
| IJR · iShares Trust | · | 1 905 226 SH | 10 września 2026 | Dziennie |
| IJT · iShares Trust | · | 182 790 SH | 9 września 2026 | Dziennie |
| IJS · iShares Trust | · | 106 293 SH | 8 września 2026 | Dziennie |
| XJR · iShares Trust | · | 4 313 SH | 31 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | · | 1 354 SH | 11 września 2026 | Dziennie |
| SMMV · iShares Trust | · | 6 367 SH | 1 września 2026 | Dziennie |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CRVL | $2.78B | 25.5 | 7.0% | 11.5% | 29.1% | 24.3% |
| RDNT | $5.28B | -285.4 | 11.5% | -0.91% | -1.9% | · |
| BLLN | $0 | 584.6 | 100.0% | 2.4% | 6.5% | 68.3% |
| LFST | $2.73B | · | 13.9% | 0.68% | 0.65% | · |
| OPCH | $5.00B | 25.1 | 13.0% | 3.7% | 15.4% | 19.3% |
| AVAH | $1.70B | 7.7 | 20.2% | 9.2% | 246.6% | 33.3% |
| GRDN | · | · | 17.9% | 3.4% | 24.8% | 20.2% |
| PRVA | $2.93B | 131.7 | 22.3% | 1.1% | 3.3% | · |
| NEO | $1.51B | -49.0 | 10.1% | -14.8% | -12.8% | 43.2% |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
Obecnie brak otwartego sygnału — żadna karta nie jest wypełniona, i to jest uczciwe.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 6, 2026